1 / 4

LAMEA Silent Heart Attack Market Size, Share, Analysis, Industry Report and Forecast to 2026

LAMEA silent heart attack market is estimated to grow at a CAGR of around 5.4% during the forecast period. Rising incidence and prevalence rate of CVD, CHD, and other heart conditions are creating the demand for the diagnosis and treatment of silent heart attacks in the LAMEA region. As per the data published by the Ministry of Health and Prevention (MOHAP), in September 2019, the prevalence of hypertension in UAE has recorded 28.8%. This represents a significant number of hypertensive patients in the country.

larebomrglobal
Download Presentation

LAMEA Silent Heart Attack Market Size, Share, Analysis, Industry Report and Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research LAMEA Silent Heart Attack Market:Industry Growth, Size, Share and Forecast 2020-2026 Request a Free Sample of Report LAMEA Silent Heart Attack Market @https://www.omrglobal.com/request- sample/lamea-silent-heart-attack-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040

  2. LAMEA silent heart attack market is estimated to grow at a CAGR of around 5.4% during the forecast period. Rising incidence and prevalence rate of CVD, CHD, and other heart conditions are creating the demand for the diagnosis and treatment of silent heart attacks in the LAMEA region. As per the data published by the Ministry of Health and Prevention (MOHAP), in September 2019, the prevalence of hypertension in UAE has recorded 28.8%. This represents a significant number of hypertensive patients in the country. Likewise, rising hypertension among patients in South Africa is expected to boost the adoption of diagnosis and treatment procedures to reduce the possibility of occurrence of severe conditions, including heart attack. The prevalence of hypertension is rising in Latin American countries owing to the significant rise in obese and overweight population, sedentary lifestyle coupled with the excessive consumption of alcohol and tobacco. As per the survey conducted by the Ministry of Health (Brazil), the obesity rate in Brazil was increased from 11.8% to 19.8% between 2006 and 2018. A full Report of LAMEA Silent Heart Attack Market at https://www.omrglobal.com/industry-reports/lamea- silent-heart-attack-market The Report Covers Comprehensive research methodology of the LAMEA silent heart attack market. This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the LAMEA silent heart attack market. Insights about market determinants which are stimulating the LAMEA silent heart attack market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/lamea-silent-heart-attack-market LAMEA Silent Heart Attack Market Segmentation By Diagnosis Electrocardiography (ECG) Magnetic Resonance Imaging (MRI) Computed Tomography (CT Scan) Echocardiography Others (Blood Test)

  3. By Treatment Medication Surgery Angioplasty Bypass Surgery Heart Transplant By End-Users Hospital & Clinics Ambulatory Surgical Centers Company Profiles Astellas Pharma Inc. AstraZeneca PLC Bayer AG Boehringer Ingelheim GmbH Boston Scientific Corp. F. Hoffmann-La Roche Ltd. GlaxoSmithKline Plc HEXACATH Medtronic PLC Merck & Co., Inc. Novartis AG Pfizer Inc. Siemens AG STENTYS SA Takeda Pharmaceutical Co. Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/lamea-silent-heart-attack-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

  4. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related